Your browser doesn't support javascript.
loading
Molecular and clinical predictors of improvement in progression-free survival with maintenance PARP inhibitor therapy in women with platinum-sensitive, recurrent ovarian cancer: A meta-analysis.
Lee, Chee Khoon; Friedlander, Michael L; Tjokrowidjaja, Angelina; Ledermann, Jonathan A; Coleman, Robert L; Mirza, Mansoor R; Matulonis, Ursula A; Pujade-Lauraine, Eric; Bloomfield, Ralph; Goble, Sandra; Wang, Ping; Glasspool, Rosalind M; Scott, Clare L.
Afiliación
  • Lee CK; National Health and Medical Research Council Clinical Trials Center, University of Sydney, Sydney, New South Wales, Australia.
  • Friedlander ML; Australia New Zealand Gynecological Oncology Group, Camperdown, New South Wales, Australia.
  • Tjokrowidjaja A; Australia New Zealand Gynecological Oncology Group, Camperdown, New South Wales, Australia.
  • Ledermann JA; University of New South Wales Clinical School, Prince of Wales Hospital, Sydney, New South Wales, Australia.
  • Coleman RL; National Health and Medical Research Council Clinical Trials Center, University of Sydney, Sydney, New South Wales, Australia.
  • Mirza MR; Australia New Zealand Gynecological Oncology Group, Camperdown, New South Wales, Australia.
  • Matulonis UA; University College London (UCL) Cancer Institute and UCL Hospitals, London, United Kingdom.
  • Pujade-Lauraine E; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bloomfield R; Department of Oncology, Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark.
  • Goble S; Nordic Society of Gynecological Oncology, Copenhagen, Denmark.
  • Wang P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Glasspool RM; Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Scott CL; Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.
Cancer ; 127(14): 2432-2441, 2021 07 15.
Article en En | MEDLINE | ID: mdl-33740262
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Quimioterapia de Mantención / Inhibidores de Poli(ADP-Ribosa) Polimerasas / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Female / Humans Idioma: En Revista: Cancer Año: 2021 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Quimioterapia de Mantención / Inhibidores de Poli(ADP-Ribosa) Polimerasas / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Female / Humans Idioma: En Revista: Cancer Año: 2021 Tipo del documento: Article País de afiliación: Australia